Cencora, Inc. announced on October 28, 2024, its participation in the White House Cancer Moonshot’s new pilot program. This initiative is specifically designed to mitigate pediatric cancer drug shortages across the United States.
The company's involvement highlights its commitment to addressing critical public health challenges and leveraging its supply chain expertise. This partnership aligns with Cencora's purpose-driven culture focused on creating healthier futures.
Participation in such a high-profile government program can strengthen Cencora's relationships with key stakeholders and reinforce its position as a vital partner in the pharmaceutical supply chain.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.